Oxycodone Hydrochloride

This article examines the use of oxycodone hydrochloride, a powerful opioid pain medication, in various clinical trials. These studies aim to evaluate the drug’s effectiveness, safety profile, and potential applications in different medical contexts, from post-surgical pain management to reformulated versions for improved bioavailability. Understanding these trials is crucial for advancing pain management strategies and ensuring patient safety.

Table of Contents

What is Oxycodone Hydrochloride?

Oxycodone hydrochloride, often simply called oxycodone, is a powerful pain medication that belongs to a class of drugs known as opioids. It is a semi-synthetic opioid, which means it is partially derived from natural sources and partially created in a laboratory[1]. Oxycodone is designed to provide effective relief for moderate to severe pain, both from cancer-related causes and other conditions[1].

Medical Uses

Oxycodone hydrochloride is primarily used to treat various types of pain, including:

  • Moderate to severe pain: This can include pain from injuries, surgeries, or chronic conditions[1].
  • Cancer-related pain: Oxycodone is often used to manage pain in cancer patients[1].
  • Osteoarthritis pain: Some studies have explored the use of oxycodone for pain relief in patients with osteoarthritis, a condition that causes joint pain and stiffness[2].
  • Post-operative pain: Research is being conducted on the use of oxycodone for pain management after surgery, including in intensive care units (ICUs)[3].

How is it Administered?

Oxycodone hydrochloride can be administered in several ways, depending on the specific formulation and the patient’s needs:

  • Oral tablets: Oxycodone is commonly available as oral tablets in various strengths, such as 5 mg, 10 mg, and 80 mg[4][1].
  • Extended-release formulations: Some versions of oxycodone are designed to release the medication slowly over time, providing longer-lasting pain relief[5].
  • Intravenous (IV) injection: In hospital settings, particularly in ICUs, oxycodone may be administered through an IV for more rapid pain relief[3].

The dosage and frequency of administration can vary widely depending on the individual patient’s needs, the severity of pain, and other factors. It’s crucial to take oxycodone exactly as prescribed by your healthcare provider.

Effectiveness

Oxycodone hydrochloride has been shown to be effective in managing various types of pain. Some key points about its effectiveness include:

  • Rapid onset: When administered intravenously, oxycodone can provide quick pain relief, with effects starting within minutes[5].
  • Long-lasting relief: Extended-release formulations can provide pain relief for extended periods, reducing the need for frequent dosing[5].
  • Comparable to other pain medications: Studies have shown that oral oxycodone can provide pain relief comparable to ibuprofen for children after fractures[5].
  • Effective for post-operative pain: Research suggests that oxycodone can be effective in managing pain after surgery, including in pediatric patients[5].

Side Effects and Safety

While oxycodone can be effective for pain management, it’s important to be aware of potential side effects and safety considerations:

  • Common side effects: These may include nausea, vomiting, constipation, drowsiness, and dizziness[5].
  • Respiratory effects: Oxycodone can affect breathing, particularly at higher doses. However, some studies suggest it may have less impact on respiratory function compared to other opioids[5].
  • Gastrointestinal effects: Constipation is a common side effect of opioids like oxycodone. Some formulations combine oxycodone with an opioid antagonist to help prevent constipation[2].
  • Risk of dependence: As with all opioids, there is a risk of developing dependence or addiction with long-term use of oxycodone[5].

It’s crucial to use oxycodone only as prescribed and to discuss any concerns or side effects with your healthcare provider.

Ongoing Research

Researchers continue to study oxycodone hydrochloride to better understand its effects and potential uses. Some areas of ongoing research include:

  • Pediatric use: Studies are investigating the safety and efficacy of oxycodone in children, particularly for post-operative pain management[5].
  • Comparison with other pain medications: Researchers are comparing oxycodone to other pain medications to determine its relative effectiveness and safety profile[6].
  • Use in intensive care: Studies are exploring the use of oxycodone for long-term pain management in ICU patients on mechanical ventilation[3].
  • Formulation improvements: Research is ongoing to develop new formulations of oxycodone that may offer improved safety or efficacy[1][4].

These ongoing studies aim to provide more information about the optimal use of oxycodone hydrochloride in various clinical settings and patient populations.

Aspect Details
Study Types Bioequivalence studies, pediatric analgesia trials, ICU pain management, pharmacokinetic evaluations
Patient Populations Healthy adults, children (ages 1-6), ICU patients on mechanical ventilation
Key Outcomes Measured Pain scores, emergence agitation, plasma drug concentrations, adverse events, extubation success rates
Formulations Studied Immediate-release tablets, extended-release tablets, intravenous infusions
Dosage Ranges 5 mg to 80 mg for oral formulations; 0.03-0.2 mg/kg/h for intravenous infusions
Comparison Drugs Remifentanil, original OxyContin formulations
Safety Monitoring Vital signs, adverse events, gastrointestinal function, respiratory depression

Ongoing Clinical Trials on Oxycodone Hydrochloride

  • Study on the Effects of Oxycodone and Paracetamol in Patients with Heart Valve or Coronary Artery Disease After Cardiac Surgery

    Recruiting

    3 1 1 1
    Finland
  • Study on How Abiraterone Affects Oxycodone in Men with Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on Opioid Detoxification Using Buprenorphine, Naloxone, and Oxycodone for Patients with Persistent Spinal Pain Syndrome Type II

    Recruiting

    3 1 1 1
    Investigated diseases:
    Belgium
  • Methoxyflurane versus oral oxycodone hydrochloride and morphine sulfate for pain relief in sickle cell disease vaso‑occlusive crises

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    France
  • Study on Methadone, Fentanyl, and Oxycodone for Reducing Pain After Heart Surgery in Adults

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Denmark
  • Study on Post-Surgery Pain Relief for Radius Fracture Patients Using Ropivacaine and Oxycodone

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Norway

Glossary

  • Analgesia: The relief of pain without loss of consciousness. In these trials, analgesia refers to the pain-relieving effects of oxycodone hydrochloride.
  • Bioequivalence: The property of two drug products having the same biological effect in terms of the rate and extent of drug absorption. This is important when comparing different formulations or manufacturing sites of oxycodone.
  • Cmax: The maximum concentration of a drug observed in the blood plasma after administration. It's a key measure in pharmacokinetic studies of oxycodone.
  • AUC (Area Under the Curve): A measure of the total exposure to a drug over time, calculated from a plot of drug concentration in blood plasma against time. It's used to assess bioequivalence and drug absorption.
  • Emergence Agitation: A state of confusion, irritability, and restlessness that can occur as a child wakes up from anesthesia. One study is examining if oxycodone can reduce this in pediatric patients.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion. This is crucial for understanding how oxycodone behaves in different patient groups.
  • CPOT (Critical Care Pain Observation Tool): A behavioral pain scale used to assess pain in critically ill patients who cannot communicate verbally. It's used in studies involving mechanically ventilated patients.
  • Fasted/Fed State: Refers to whether a participant has eaten before receiving the medication. Some studies compare how food affects the absorption and effectiveness of oxycodone.
  • Tamper-Resistant Formulation: A drug formulation designed to prevent misuse or abuse. Some studies are examining reformulated, tamper-resistant versions of oxycodone.
  • Mechanical Ventilation: The use of a machine to assist or replace spontaneous breathing. One study is looking at oxycodone use in patients requiring this support in the ICU.

References

  1. https://clinicaltrials.gov/study/NCT01101321
  2. https://clinicaltrials.gov/study/NCT02032927
  3. https://clinicaltrials.gov/study/NCT06444997
  4. https://clinicaltrials.gov/study/NCT01101308
  5. https://clinicaltrials.gov/study/NCT06665048
  6. https://clinicaltrials.gov/study/NCT06212622